No Data
No Data
Jazz Pharmaceuticals(JAZZ.US) Officer Sells US$17,738.48 in Common Stock
$Jazz Pharmaceuticals(JAZZ.US)$ Officer Carr Patricia sold 163 shares of common stock on Jun 7, 2024 at an average price of $108.825 for a total value of $17,738.48.Source: Announcement What is statem
'Load Up,' Says Goldman Sachs About These 2 Strong Buy Stocks
RBC Capital Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $176
RBC Capital analyst Gregory Renza maintains $Jazz Pharmaceuticals(JAZZ.US)$ with a buy rating, and maintains the target price at $176.According to TipRanks data, the analyst has a success rate of 45.4
Goldman Starts Jazz at Buy, Cites Diversified Portfolio
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Jazz Pharmaceuticals (NASDAQ:JAZZ) in the last three months.The table below summarizes their re
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.